Literature DB >> 6289061

Animal studies on the efficacy of vaccination against recurrent herpes.

M Scriba.   

Abstract

Guinea pigs, latently infected with herpes simplex virus type 2 (HSV 2), were immunized with an HSV 2 vaccine derived from extracts of infected cells and either formol inactivated or detergent treated. Although such postinfection vaccination could significantly increase the titers of neutralizing antibodies, it had no effect on the course of recurrent herpes in these animals.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6289061     DOI： 10.1007/bf02122705

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


  34 in total

1.  VACCINE THERAPY IN RECURRENT HERPES SIMPLEX.

Authors:  A B KERN; B L SCHIFF
Journal:  Arch Dermatol       Date:  1964-06

2.  Defective in vitro lymphoproliferative responses to herpes simplex virus in patients with frequently recurring herpes infections during the disease-free interval.

Authors:  H Kirchner; M Schwenteck; H Northoff; E Schöpf
Journal:  Clin Immunol Immunopathol       Date:  1978-11

3.  Herpes simplex virus vaccines.

Authors:  T G Wise; P R Pavan; F A Ennis
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

4.  Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.

Authors:  R J O'Reilly; A Chibbaro; E Anger; C Lopez
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

5.  Protection of guinea pigs against primary and recurrent genital herpes infections by immunization with live heterologous or homologous Herpes simplex virus: implications for a herpes virus vaccine.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

6.  Efficacy of a nucleic acid free herpetic subunit vaccine.

Authors:  R Cappel; F de Cuyper; F Rickaert
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

7.  Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay.

Authors:  C Lopez; R J O'Reilly
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

8.  Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans.

Authors:  E J Shillitoe; J M Wilton; T Lehner
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

Review 9.  Immunology of herpes simplex virus infection: relevance to herpes simplex virus vaccines and cervical cancer.

Authors:  A J Nahmias; S L Shore; S Kohl; S E Starr; R B Ashman
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

10.  Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice.

Authors:  R J Klein; E Buimovici-Klein; H Moser; R Moucha; J Hilfenhaus
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574
View more
  3 in total

1.  Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2.

Authors:  M Bröker; K J Abel; R Köhler; J Hilfenhaus; E Amann
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

2.  Zwitterionic detergent solubilisation of HSV-1 surface antigens.

Authors:  R Jennings; T Quasim; R M Sharrard; D Hockley; C W Potter
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 3.  Developments in herpes simplex virus vaccines: old problems and new challenges.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.